NCT06036134

Brief Summary

COVID-19 vaccines are available to children over six months, and these vaccines are powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have lower COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication and public health experts proposes a community-based theory-driven intervention that utilizes culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19 vaccine hesitancy and increase their children's vaccine uptake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.8 years

First QC Date

September 5, 2023

Last Update Submit

January 23, 2026

Conditions

Keywords

COVID-19 VaccineDigital storytellingHispanic childrenVaccine hesitancyHealth disparities

Outcome Measures

Primary Outcomes (3)

  • Parental COVID-19 vaccine hesitancy

    Parental COVID-19 vaccine hesitancy will be measured at three time points. The investigators will use a modified version of the Parent Attitudes About Childhood Vaccines (PACV) Survey to assess changes in parental vaccine hesitancy (15 items). Scores range from 0-30, with more points equating to greater vaccine hesitancy. For all responses, vaccine-hesitant responses are equal to 2 points, neutral or unsure responses are worth 1 point, and non-hesitant responses are worth 0 points. There are 2 questions which require a slider response. For these two questions, scores of 0-5 signify vaccine hesitancy (2 points), 6-7 signify unsure/neutral responses (1 point), and 8-10 illustrate non-hesitant scores (0 points).

    Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)

  • Intentions to vaccinate child(ren) against COVID-19

    Measured via a previously validated survey item based on Theory of Planned Behavior constructs, updated to reflect COVID-19 vaccination among children. There is one question about parents' intentions to vaccinate their children. The response option is a 7-point Likert Scale (1 = strongly disagree, 4 = neither disagree nor agree, 7 = strongly agree), with 1 signifying no intention to vaccinate and 7 signifying the parent is very likely to vaccinate their child(ren). Higher scores indicate great intentions to vaccinate children against COVID-19.

    Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)

  • Child's COVID-19 vaccine uptake

    Measured with two items (yes/no response options) with one question assessing whether children have received 1 or more doses of COVID-19 vaccines over the past two months. Affirmative responses will equal one point, and "no" responses will equal no points.

    T3 (2-months post-intervention)

Secondary Outcomes (3)

  • Parents' attitudes about vaccinating their child(ren) against COVID-19

    Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)

  • Parents' perceived norms about vaccinating their child(ren) against COVID-19

    Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)

  • Parents' perceived behavioral control to vaccinate their child(ren) against COVID-19

    Baseline (T1), T2 (after 4-week intervention), and T3 (2-months post-intervention)

Study Arms (2)

Baseline and Digital Storytelling (DST)

EXPERIMENTAL

Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to DST arm. The intervention group participants will watch the four selected digital stories about COVID-19 vaccine experiences among Hispanic parents of children. Each story was made with voice, images, and sound (3-5 minutes each). Intervention group participants will complete the Time 2 (T2) online survey immediately after the DST intervention. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).

Behavioral: Baseline surveysBehavioral: Digital Storytelling Intervention

Baseline and Control

ACTIVE COMPARATOR

Once participants complete the consent, they will be asked to complete a baseline assessment using the web-based data collection platform, Research Electronic Data Capture before the random assignment to control arm. Control group participants will receive a CDC COVID-19 Vaccine Information Sheet appropriate for their child's age before completing the T2 assessment. Two months later, the investigators will contact all participants and ask them to complete another follow-up (T3) assessment of participants' vaccine hesitancy and COVID-19 vaccination behaviors (since T1 and T2).

Behavioral: Baseline surveysBehavioral: Information Control Intervention

Interventions

Baseline surveys contained a series of scaled questions, including sociodemographic variables (age, gender, income, education level, relationship to the child), parental COVID-19 vaccine hesitancy, intentions to vaccinate child against COVID-19, and parents' attitudes, perceived norms, and perceived behavioral control about vaccinating their child against COVID-19,

Also known as: Baseline questionnaire
Baseline and ControlBaseline and Digital Storytelling (DST)

In Aim 1, the investigators are creating intervention materials for Study Aim 2. These intervention materials include ten digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. Each story uses individuals' own brief first-person visual narratives/stories that use digital images, audio recordings, music, and text to document personal experiences.

Also known as: Digital Storytelling, Storytelling
Baseline and Digital Storytelling (DST)

The control group participants will receive a CDC COVID-19 vaccine information sheet appropriate for their child's age.

Also known as: Control Intervention
Baseline and Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-identifies as Hispanic
  • is a biological parent or a legal guardian of at least one child under 18 years old
  • their child(ren) are not vaccinated against up-to-date with COVID-19 vaccine doses
  • agrees to send and receive a text message and submit a photo of their child's immunization record for T3 data collection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona State University

Phoenix, Arizona, 85004, United States

Location

MeSH Terms

Conditions

Vaccine-Preventable DiseasesCOVID-19Health BehaviorBehaviorNarrationVaccination Hesitancy

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

InfectionsPneumonia, ViralPneumoniaRespiratory Tract InfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesCommunicationVaccination RefusalTreatment RefusalTreatment Adherence and Compliance

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Alexis Koskan, Ph.D

    Arizona State University

    PRINCIPAL INVESTIGATOR
  • Sunny W Kim, Ph.D

    Arizona State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 13, 2023

Study Start

December 1, 2023

Primary Completion

August 31, 2025

Study Completion

August 31, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Locations